Visium Asset Management’s Idexx Laboratories IDXX Stock Holding History

Visium Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,920	Closed	-$217K	–	1103
2014 Q4	$217K	Buy	+2,920	New	+$205K	﹤0.01%	962
2013 Q4	–	Sell	-74,402	Closed	-$3.71M	–	925
2013 Q3	$3.71M	Buy	74,402 +34,402	+86%	+$1.65M	0.08%	182
2013 Q2	$1.8M	Buy	+40,000	New	+$1.75M	0.04%	246

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Visium Asset Management's IDXX Position: Q1 2015 in Review

Visium Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2015, closing a stake of 2,920 shares — an estimated $217K sold.

Visium Asset Management first reported a position in IDXX in Q2 2013 and held it in 3 quarters. The position peaked at $3.71M in Q3 2013. 344 funds tracked by Wall St. Rank hold IDXX as of Q1 2015.

Visium Asset Management reported no remaining Idexx Laboratories position as of Q1 2015 after selling out during the quarter.
Visium Asset Management sold 2,920 Idexx Laboratories shares in Q1 2015, an estimated $217K.
Visium Asset Management first reported a position in Idexx Laboratories in Q2 2013 and held it in 3 quarters.
Visium Asset Management's Idexx Laboratories position peaked at $3.71M in Q3 2013.
344 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2015.

Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.